🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

14 recruiting trials

for Cardiorenal Syndrome

Sodium-Glucose Cotransporter-2 Inhibitor for Patients With Acute Cardiorenal Syndrome NCT07273838Phase 22 sites📍 New Haven📍 New Haven Yale University · Tests: Dapagliflozin 10mg Tab, Placebo Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients NCT07167368NA1 site📍 Nantong Haiyan Pan · Tests: Standardized Basic Drug Therapy for HFrEF with Chronic Kidney Dysfunction, Home-based Personalized Exercise Rehabilitat… Feasibility of the SCD in Cardiorenal Syndrome Patients Awaiting LVAD NCT03836482NA1 site📍 Ann Arbor SeaStar Medical · Tests: Selective Cytopheretic Device Dapagliflozin for Cardio-renal Protection After ICU Discharge NCT07025629Phase 32 sites📍 Paris📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: Dapagliflozin 10 MG Oral Tablet [Farxiga], One tablet of placebo of dapagliflozin 10 mg The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 NCT06030843Phase 2, Phase 31 site📍 Bangkok Chulalongkorn University · Tests: Empagliflozin 10 MG, Placebo Venous Ultrasound Guided Organ Decongestion in Patients Hospitalized with Acute Decompensated Heart Failure NCT06714409NA1 site📍 Oslo Oslo University Hospital · Tests: VExUS guided decongestion Cardio-Renal Registry NCT06521801n/a1 site📍 London Queen Mary University of London · Tests: Observation Optimised Cardiovascular and Renal Protection in Patients With Chronic Kidney Disease and Cardiovascular Disease NCT07835828NA1 site📍 Svendborg Odense University Hospital · Tests: Multidisciplinary Cardio-Renal Care Evaluation of the Impact of Interventional Treatments for Symptomatic, Severe Tricuspid Valve Insufficiency on Renal Integrity and Function, as Well as on Physical Function and Activity in Older Adults. NCT07464106n/a1 site📍 Stuttgart Robert Bosch Medical Center · Tests: Transcatheter edge-to-edge repair (TEER) Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure NCT05677100NA50 sites📍 Phoenix📍 Phoenix📍 Scottsdale Procyrion · Tests: Aortix System Research on Optimal Diagnosis and Treatment of Cardiorenal Syndrome NCT05397392n/a1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: guideline recommended routine treatment Peritoneal Ultrafiltration in Cardio Renal Syndrome. NCT03994874Phase 1, Phase 23 sites📍 Chieti📍 Milan📍 Naples Iperboreal Pharma Srl · Tests: PolyCore (Polydextrin, L-Carnitine, D-xylitol) The Role of intraABDOminal Pressure and Point Of Care UltraSound to Guide Decongestive Therapy in Heart Failure NCT07008365Phase 32 sites📍 Zaragoza📍 Zaragoza Instituto de Investigación Sanitaria Aragón · Tests: Furosemide 20 Milligrams Screening of Predictive Biomarkers for Cardiorenal Syndrome NCT07139626n/a1 site📍 Nantong Haiyan Pan · Tests: This is an observational Study.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy